Update on fundamental mechanisms of thyroid cancer A Prete, P Borges de Souza, S Censi, M Muzza, N Nucci, M Sponziello Frontiers in endocrinology 11, 102, 2020 | 349 | 2020 |
Contemporary thyroid nodule evaluation and management G Grani, M Sponziello, V Pecce, V Ramundo, C Durante The Journal of Clinical Endocrinology & Metabolism 105 (9), 2869-2883, 2020 | 248 | 2020 |
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells M Sponziello, F Rosignolo, M Celano, V Maggisano, V Pecce, ... Molecular and cellular endocrinology 431, 123-132, 2016 | 137 | 2016 |
Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up F Rosignolo, M Sponziello, L Giacomelli, D Russo, V Pecce, M Biffoni, ... Journal of the Endocrine Society 1 (1), 3-13, 2017 | 89 | 2017 |
Indoleamine 2, 3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment S Moretti, E Menicali, P Voce, S Morelli, S Cantarelli, M Sponziello, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), E832-E840, 2014 | 87 | 2014 |
MicroRNA-based molecular classification of papillary thyroid carcinoma F Rosignolo, L Memeo, F Monzani, C Colarossi, V Pecce, A Verrienti, ... International journal of oncology 50 (5), 1767-1777, 2017 | 85 | 2017 |
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy A Di Costanzo, F Belardinilli, D Bailetti, M Sponziello, L D’Erasmo, ... Scientific reports 8 (1), 3702, 2018 | 80 | 2018 |
Thyroid hormone therapy in differentiated thyroid cancer G Grani, V Ramundo, A Verrienti, M Sponziello, C Durante Endocrine 66 (1), 43-50, 2019 | 76 | 2019 |
AUTHOR COPY ONLY M D’Agostino, M Sponziello, C Puppin, M Celano, V Maggisano, F Baldan, ... Endocrinology 52, 121-131, 2014 | 68 | 2014 |
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours M Sponziello, C Durante, A Boichard, M Dima, C Puppin, A Verrienti, ... Molecular and cellular endocrinology 392 (1-2), 8-13, 2014 | 67 | 2014 |
Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer L Lamartina, G Grani, M Biffoni, L Giacomelli, G Costante, S Lupo, ... The Journal of Clinical Endocrinology & Metabolism 101 (8), 3036-3044, 2016 | 63 | 2016 |
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells M Sponziello, A Verrienti, F Rosignolo, RF De Rose, V Pecce, ... Endocrine 50, 434-441, 2015 | 60 | 2015 |
Clinical exome performance for reporting secondary genetic findings JY Park, P Clark, E Londin, M Sponziello, LJ Kricka, P Fortina Clinical chemistry 61 (1), 213-220, 2015 | 51 | 2015 |
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation C Puppin, C Durante, M Sponziello, A Verrienti, V Pecce, E Lavarone, ... Endocrine 47, 528-536, 2014 | 49 | 2014 |
A novel de novo germ‐line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional … MD Castellone, A Verrienti, D Magendra Rao, M Sponziello, D Fabbro, ... Clinical endocrinology 73 (4), 529-534, 2010 | 48 | 2010 |
Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound G Grani, V Ramundo, R Falcone, L Lamartina, T Montesano, M Biffoni, ... The Journal of Clinical Endocrinology & Metabolism 104 (11), 4981-4989, 2019 | 45 | 2019 |
Low‐risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach V Ramundo, M Sponziello, R Falcone, A Verrienti, S Filetti, C Durante, ... Journal of surgical oncology 121 (6), 958-963, 2020 | 42 | 2020 |
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells V Maggisano, M Celano, GE Lombardo, SM Lepore, M Sponziello, ... Molecular and cellular endocrinology 448, 34-40, 2017 | 41 | 2017 |
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules M Sponziello, C Brunelli, A Verrienti, G Grani, V Pecce, L Abballe, ... Endocrine 68, 458-465, 2020 | 34 | 2020 |
RET mutation and increased angiogenesis in medullary thyroid carcinomas A Verrienti, G Tallini, C Colato, A Boichard, S Checquolo, V Pecce, ... Endocrine-related cancer 23 (8), 665-676, 2016 | 31 | 2016 |